Tag:
CRLX101
Latest Headlines
Latest Headlines
Cerulean Pharma enrolling for Phase 2 lung cancer trial
Cerulean Pharma is moving on to a Phase 2 clinical trial of its new lung cancer drug, CRLX101, boosted by early clinical results suggesting that the treatment is well-tolerated and possibly stops the...
